On CNBC’s “Halftime Report,” Pete Najarian said he loved both Pfizer Inc PFE and Alcoa Corp AA.
Alcoa does stand out right now because “there’s so much in the material space going forward,” he commented.
Najarian added, however, recommended Pfizer for investors with a long-term horizon because the stock is stable and offers a great dividend yield. One can also sell options against it.
Pfizer is a “quality company with a great balance sheet,” Najarian said, while adding this is a stock that one could own going forward.
Between Alcoa and Pfizer, the latter is the more “comfortable one to pick right now.”
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.